Analysis of Blood Spot 17-Hydroxyprogesterone Concentration According to Gestational Age and Birth Weight / 대한임상병리학회지
Korean Journal of Clinical Pathology
;
: 104-108, 2001.
Artículo
en Coreano
| WPRIM
| ID: wpr-170048
ABSTRACT
BACKGROUND:
High levels of 17-hydroxyprogesterone (17-OHP) are frequently observed in premature infants without congenital adrenal hyperplasia. The purpose of this study is to set cut-off limits of 17-OHP on the basis of gestational age at birth and birth weight.METHODS:
Blood spot 17-OHP concentrations were measured in 1,000 infants on the 3th day of life at Inha University Hospital. An enzyme-linked immunosorbent assay (ELISA) method (ICN Neoscreen ELISA 17-hydroxyprogesterone kit, ICN Pharmaceuticals. Inc., Japan) was used. The values obtained were analyzed with respect to birth weight and gestational age at birth in order to decide the appropriate cut-off limits in a neonatal mass screening for 21-hydroxylase deficiency.RESULTS:
In the neonatal mass screening for CAH, the cut-off limits for determining the 17-OHP for recall, were decided as follows (1) 57.65, 39.88, 33.52 ng/mL for gestational age at birth of 35 weeks or less, 36-37, and 38 weeks or more, respectively, and (2) 54.88, 43.86, 32.92 ng/mL for birth weight of 2.49 or less, 2.50-2.99, 3.00 kg or more, respectively.CONCLUSIONS:
The cut-off limits on the basis of gestational age at birth and birth weight should be used in the screening for congenital adrenal hyperplasia. We believe that the false positive rate in premature infants can be reduced using this method.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Peso al Nacer
/
Recien Nacido Prematuro
/
Ensayo de Inmunoadsorción Enzimática
/
Esteroide 21-Hidroxilasa
/
Tamizaje Masivo
/
Edad Gestacional
/
Tamizaje Neonatal
/
Hiperplasia Suprarrenal Congénita
/
17-alfa-Hidroxiprogesterona
/
Parto
Tipo de estudio:
Estudio de tamizaje
Límite:
Humanos
/
Lactante
/
Recién Nacido
Idioma:
Coreano
Revista:
Korean Journal of Clinical Pathology
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS